Facetime with Phil: Off-Label vs. Investigational Drug Use

In video two of the four-part Facetime with Phil video blog series on off-label drug use, myMatrixx Chief Clinical Officer Phil Walls contrasts off-label drug use with investigational drug use and provides insight on situations where prescribing drugs for off-label use may be appropriate–and when they are not.

BACK TO ALL VIDEOS

OTHER VIDEOS IN THIS SERIES

DEFINING OFF-LABEL DRUG USE FDA’S NEW POSITION ON OFF-LABEL DRUG USE

POTENTIAL IMPACT ON WORKERS’ COMP ARE COMPOUNDS OFF LABEL OR EXPERIMENTAL?

INAPPROPRIATE WARNINGS FOR OPIOIDS